{"abstract":"The Drug Enforcement Administration (DEA) jointly with the Department of Health and Human Services (HHS) is issuing a fourth extension of telemedicine flexibilities for the prescribing of controlled medications through December 31, 2026.","action":"Temporary rule.","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"},{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2025/12/31/2025-24123.html","cfr_references":[{"chapter":null,"citation_url":null,"part":1307,"title":21},{"chapter":null,"citation_url":null,"part":12,"title":42}],"citation":"90 FR 61301","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"This rule is effective January 1, 2026 through December 31, 2026.","disposition_notes":null,"docket_ids":["Docket No. DEA-407"],"dockets":[{"supporting_documents":[],"agency_name":"DEA","documents":[{"comment_count":0,"comment_start_date":"2025-12-31","updated_at":"2026-01-12T17:56:00.052-05:00","comment_url":"https://www.regulations.gov/commenton/DEA-2023-0029-41937","allow_late_comments":false,"id":"DEA-2023-0029-41937","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"DEA-2023-0029","title":"Telemedicine Prescribing of Controlled Substances (DEA407)"},{"supporting_documents":[],"agency_name":"HHS","documents":[{"comment_count":0,"comment_start_date":"2025-12-31","updated_at":"2025-12-31T09:00:09.207-05:00","comment_url":"https://www.regulations.gov/commenton/HHS_FRDOC_0001-1015","allow_late_comments":false,"id":"HHS_FRDOC_0001-1015","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"HHS_FRDOC_0001","title":"Recently Posted HHS Rules and Notices."}],"document_number":"2025-24123","effective_on":"2026-01-01","end_page":61306,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2025/12/31/2025-24123.xml","html_url":"https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2025-24123?publication_date=2025-12-31","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2025-12-31/2025-24123/mods.xml","not_received_for_publication":null,"page_length":6,"page_views":{"count":42986,"last_updated":"2026-06-01 12:15:06 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-12-31/pdf/2025-24123.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-24123.pdf?1767102321","publication_date":"2025-12-31","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2025/12/31/2025-24123.txt","regulation_id_number_info":{"1117-AB40":{"issue":"202504","html_url":"https://www.federalregister.gov/regulations/1117-AB40/special-registrations-for-telemedicine-and-limited-state-telemedicine-registrations","title":"Special Registrations for Telemedicine and Limited State Telemedicine Registrations","xml_url":"http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=202504&RIN=1117-AB40&operation=OPERATION_EXPORT_XML","priority_category":"Other Significant"},"1117-ZA07":null,"1117-AB78":{"issue":"202504","html_url":"https://www.federalregister.gov/regulations/1117-AB78/expansion-of-induction-of-buprenorphine-via-telemedicine-encounter-","title":"Expansion of Induction of Buprenorphine via Telemedicine Encounter\n","xml_url":"http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=202504&RIN=1117-AB78&operation=OPERATION_EXPORT_XML","priority_category":"Other Significant"}},"regulation_id_numbers":["1117-AB40","1117-AB78","1117-ZA07"],"regulations_dot_gov_info":{"supporting_documents":[],"regulatory_plan":{"html_url":"https://www.federalregister.gov/regulations/1117-AB40/special-registrations-for-telemedicine-and-limited-state-telemedicine-registrations","title":"Special Registrations for Telemedicine and Limited State Telemedicine Registrations"},"comments_count":0,"agency_id":"DEA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=DEA-2023-0029","supporting_documents_count":0,"docket_id":"DEA-2023-0029","document_id":"DEA-2023-0029-41937","regulation_id_number":"1117-AB40","title":"Telemedicine Prescribing of Controlled Substances (DEA407)","checked_regulationsdotgov_at":"2026-01-14T02:55:03Z"},"regulations_dot_gov_url":null,"significant":true,"signing_date":null,"start_page":61301,"subtype":null,"title":"Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications","toc_doc":"Fourth Temporary Extension of COVID19 Telemedicine Flexibilities for Prescription of Controlled Medications","toc_subject":null,"topics":["Administrative practice and procedure","Drug traffic control","Prescription drugs"],"type":"Rule","volume":90}